Navigation Links
iBio, Inc. Receives Approval from NYSE MKT of Compliance Plan
Date:2/13/2013

NEWARK, Del., Feb. 13, 2013 /PRNewswire/ -- iBio, Inc. (NYSE MKT: IBIO) today announced that it has been notified by the NYSE MKT (the "Exchange") Staff that the Exchange has accepted the Company's plan of compliance which was submitted on December 21, 2012.  The plan submitted in December 2012 was in response to the Staff's notice that the Company was not in compliance with the Exchange's continued listing requirement set forth in Section 1003(a)(iii) of the NYSE MKT Company Guide.  This rule requires a listed company to have stockholders' equity of at least  $6,000,000 if it has experienced net losses in its five most recent fiscal years.  In connection with accepting the Company's compliance plan, the Exchange has granted the Company an extension until October 14, 2013 to regain compliance with the $6,000,000 stockholders' equity requirement.

(Logo: http://photos.prnewswire.com/prnh/20120419/NY91086LOGO )

During the extension period, the Company will be subject to periodic review by the Staff of the Exchange.  The failure by the Company to make progress consistent with the accepted plan or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the Exchange.

In addition to the foregoing, the Company expects to receive notice from the Exchange that it does not satisfy the $4,000,000 stockholders' equity requirement set forth in  Section 1003(a)(ii) of the NYSE MKT Company Guide following the filing of its Form 10-Q for the quarterly period ended December 31, 2012, since it experienced net losses in three of its most recent four fiscal years.  The Company anticipated this when it submitted its compliance plan and designed the compliance plan, which has now been accepted, to address its non-compliance with both the $6,000,00
'/>"/>

SOURCE iBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project
2. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
3. Remique (TM), a Revolutionary Dietary Supplement, Manufactured in FDA Registered Facilities, Receives Raves from Compromised Immune System Sufferers
4. Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits
5. Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
6. Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award
7. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
8. Virtual Ports Receives Patent Approvals in the United States and Japan
9. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
10. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
11. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Craniomaxillofacial Implants Market ... and Forecast 2014 - 2022" report to ... craniomaxillofacial implants market studies the current and future ... rapidly gaining popularity in the global market due ...
(Date:7/28/2015)... 28, 2015 The Physician-Patient Alliance for Health ... campaign, " Surviving Your Hospital Stay ." ... deserve! None of these patients went home from hospital," ... Director, PPAHS) referring to the patient stories ... Coalition to Promote Continuous Monitoring of Patients on Opioids ...
(Date:7/28/2015)... --  Vincari , known for their Lightspeed Valet ... John O,Neil as their Executive Vice President of ... of diverse and progressive experience within the healthcare industry ... with Vincari,s CMO, Dr. Lucian Newman,s experience ... challenges both hospitals and surgeons face, including the need ...
Breaking Medicine Technology:Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... Performance of Abbott,s ARCHITECT Tacrolimus Assay, Only,Automated Transplant Monitoring Test ... ... Low-Level Monitoring, WASHINGTON, July 30 The ability of ... in kidney,transplant patients may make a significant difference in assuring ...
... 30 Scimitar Equity, LLC issues a review ... "RapidMist(TM),the Non-Invasive Oral Drug Delivery Platform, Sets the ... Pipeline and Global Revenues.", This review is ... is engaged in the research, development, and commercialization,of ...
Cached Medicine Technology:Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 2Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 3Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC 2
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, the ... home of Zerorez Indianapolis, which plans to expand across the state. , Ray Kennedy, ... second full year in business and we should double our first year’s revenue. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... Group, which Breckheimer oversees. In her role, Powers is responsible for driving growth ... the announcement, Breckheimer commented, “Gina’s track record as an effective leader within the ...
(Date:7/28/2015)... ... July 29, 2015 , ... Talking About Your Product Pipeline:, How FDA ... – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , When a company has a product ... say about it is tightly regulated by the FDA. , At the same time, ...
(Date:7/28/2015)... ... , ... Every July, since 2007, about 25 pediatric pulmonary hypertension (PH) patients ... television. They go to summer camp. , PH is incurable and life threatening, as ... pushes hard to get blood through arteries in the lungs narrowed by the disease. ...
Breaking Medicine News(10 mins):Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
... cholesterol level in blood.,High level of cholesterol, which is ... can lead to serious health risks. ,// ,Researchers ... examined 199 healthy middle-aged men and women to know ... can increase cholesterol and heighten cardiovascular risk, reports Newswise ...
... of bird flu, even as the government has given approval ... ,The latest outbreaks of the deadly H5N1 strain of ... southwestern province of Yunnan and the northwestern region of Ningxia, ... birds died in Yunnan's Chuxiong district Thursday, and 230 died ...
... is planning expansion of its super-speciality hospital chain with ... Kolkata and Bangalore.// ,"We have embarked on the ... Delhi) which would be ready by 2007-end. We also ... the chain's vice president, told IANS., ,Unlike the ...
... more than 1,200 children, whose organs were removed after death ... average of about ?2,900 in a compensation deal announced recently ... the apex body had fought the cases involving organ-retention ... to a total figure of around ?3.6 million for the ...
... people could be putting their health at risk by ... and other health professionals.// ,The survey of more ... Health Professions Council (HPC), found that about 81% of ... professional were oblivious to whether they were properly qualified ...
... juice has anti-bacterial properties? It has now been found ... compounds that can help preserve dental health by prevention ... University of Rochester Medical Center have been credited with ... acts just similar to a Teflon sheath, commonly used ...
Cached Medicine News:Health News:Wockhardt Group Plans Hospital In Delhi By End-2007 2Health News:Organ Scandals Compensation And The Aftermath 2Health News:Credentials Of Specialists Need To Be Checked 2Health News:Cranberry juice to Prevent Dental Decay 2
The Heine C series binocular loupes offer extremely low weight (46 g), crisp views, and quality German construction in an affordable instrument....
Easyloupes are exceptional optics that you have come to expect from Oculus. Available in either 1.8x or 2.5x magnification and 40 cm working distance (15.75 inches), they have the well-known durabili...
Includes near contrast sensitivity card, calibrated holder, light meter, answer key and instruction manual contrast vision test developed by Arthur P. Ginsburg, Ph.D....
Near PT test card/shorthand /PH stock market 5 1/2 " X 8"...
Medicine Products: